COMMUNIQUÉS West-GlobeNewswire

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
21/10/2024
CARSON CITY, Nev., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
HealthEx Raises $14M led by General Catalyst to Empower Patients and Health Systems to do more with Health Data
21/10/2024
HealthEx’s AI-driven preference and consent platform simplifies patient experience, automates security and compliance for healthcare organizations, unlocking how data can be used for good SAN FRANCISCO, Oct. 21, 2024 ( [...]
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days
21/10/2024
WARREN, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]
AAMI, GCEA Translate HTM Guide into Spanish, Chinese, More
21/10/2024
AAMI Benchmarking Guide Now Free in Four New Languages Arlington, Oct. 21, 2024 (GLOBE NEWSWIRE) -- A new resource is available for clinical engineers and healthcare technology management (HTM) professionals just in [...]
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees
21/10/2024
ZUG, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program committees expanded with [...]
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
21/10/2024
PRESS RELEASE REGULATED INFORMATION 21 October 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 21 October 2024 – Sequana Medical NV (Euronext Brussels: [...]
Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details
21/10/2024
BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will [...]
Valneva to Present on Chikungunya at Several Leading Scientific Conferences
21/10/2024
Saint-Herblain (France), October 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today that members of its senior leadership team will present datasets on the world’s [...]
Valneva effectuera des présentations sur le chikungunya lors de différentes conférences scientifiques de premier plan
21/10/2024
Saint-Herblain (France), le 21 octobre 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, annonce aujourd'hui que des membres de son équipe de direction présenteront des données [...]
BioPorto A/S Announces Changes to the US Commercial Organization
21/10/2024
October 21, 2024 News release BioPorto A/S Announces Changes to the US Commercial Organization COPENHAGEN, DENMARK and BOSTON, MA, USA, October 21, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH: [...]
Responsibility statement for first half year of 2024
21/10/2024
Please find attached the first half 2024 financial report including the Responsibility Statement. ***** For further information, please contact: Alexander Karlsen CFO +47 97 05 36 21 Alexander.karlsen@vistin.com This [...]
The Froedtert & MCW Health Network Engages Digital Platform to Roll Out Clinical Nutrition Program to Patients and Employees
21/10/2024
Integrating the Season Health clinical nutrition program into the Xealth digital health platform streamlines provider referral flow, increasing access and improving outcomes MILWAUKEE and SEATTLE, Oct. 21, 2024 (GLOBE [...]
KFSHRC Leads the Way in AI-Powered Diagnostics and Minimally Invasive Surgeries
20/10/2024
RIYADH, Saudi Arabia, Oct. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to contribute to advancing healthcare through pioneering advancements in AI-driven [...]
Le KFSHRC, pionnier du traitement du cancer grâce à ses thérapies novatrices et ses résultats exceptionnels
20/10/2024
RIYAD, Arabie saoudite, 20 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (« KFSHRC ») révolutionne le traitement du cancer dans la région grâce à des thérapies transformatrices [...]
KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional Outcomes
19/10/2024
RIYADH, Saudi Arabia, Oct. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing cancer treatment in the region with transformative therapies like CAR-T cell [...]
Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia
19/10/2024
NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing Phase 1a/1b clinical trial Responses are durable and deepen over time [...]
Le KFSHRC impose son leadership en matière de veille dans les soins de santé pour le diagnostic et les soins aux patients
19/10/2024
RIYAD, Arabie Saoudite, 19 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) contribue à l’innovation mondiale en matière de soins de santé, en tirant parti de l’ [...]
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
19/10/2024
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today [...]
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
19/10/2024
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ) is a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified [...]

Pages